US Navy Official Confirms 14 Billion Arms Sale to Taiwan Paused Amid Iran Tensions Custard Apple Market Faces Export Challenges Despite Crop Resilience Renegades Belmont Stakes Bid Could Shape Horse Racing Betting Market Rubio Assures NATO Allies on US Troop Deployment Plans Amid Policy Uncertainty Traders Bet on IonQ Micron and Anduril as Potential Next Targets for US Government Stake Wellness Industry Growth Sauna Health Benefits Highlighted in Fortune Report PermaFix Environmental Services Inc PESI Q1 2026 Earnings EPS Misses Estimates as Losses Widen ERIE Q1 2026 Earnings Earnings Miss Estimates Amidst Rising Costs VEL Q1 2026 Earnings EPS Beats Estimates but Stock Dips 217 CHAI Q4 2025 Earnings Massive Earnings Miss Highlights Ongoing Challenges PCOR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gains UNF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower MARA Holdings MARA Declines 21 as Bitcoin Volatility Weighs on Mining Stocks Insight Molecular Diagnostics Inc IMDX Gains 575 as Momentum Builds Toward Key Resistance Pegasystems PEGA Slips 169 as Shares Test Support Levels Mereo BioPharma MREO Tests Key Support at 031 After Modest Decline Ranger Energy Services RNGR Posts Modest Gain Consolidating Between Key Levels Trump Pressures Bank of America and JPMorgan to Halt Alleged Discrimination Against Conservatives MBIN Q1 2026 Earnings EPS Beat of 502 Surprises Analysts Yet Stock Declines FMX Stock Holds Steady Near 121 as Support and Resistance Levels Define Trading Range GOOGL Q1 2026 Earnings EPS Misses Amid Accelerated AI Investments LMAT Q1 2026 Earnings Modest EPS Beat Amid Revenue Data Gap GHM Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance Lite Strategy Inc LITS Q4 2024 Earnings EPS Misses Estimates by Wide Margin Stock Declines LCTX Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue Abivax ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Costs SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress